115 related articles for article (PubMed ID: 7955606)
21. Dehydroepiandrosterone sulfate is positively correlated with soluble interleukin 2 receptor and soluble intercellular adhesion molecule in systemic lupus erythematosus.
Straub RH; Zeuner M; Antoniou E; Schölmerich J; Lang B
J Rheumatol; 1996 May; 23(5):856-61. PubMed ID: 8724298
[TBL] [Abstract][Full Text] [Related]
22. Polymyalgia rheumatica and giant cell arteritis: circulating immune complexes.
Espinoza LR; Bridgeford P; Lowenstein M; Bocanegra TS; Vasey FB; Germain BF
J Rheumatol; 1982; 9(4):556-60. PubMed ID: 6215486
[TBL] [Abstract][Full Text] [Related]
23. Antibodies to cardiolipin and beta 2 glycoprotein I in patients with polymyalgia rheumatica and giant cell arteritis.
Meyer O; Nicaise P; Moreau S; de Bandt M; Palazzo E; Hayem G; Chazerain P; Labarre C; Kahn MF
Rev Rhum Engl Ed; 1996 Apr; 63(4):241-7. PubMed ID: 8738442
[TBL] [Abstract][Full Text] [Related]
24. [Coexistence of polymyalgia rheumatica/temporal arteritis and chronic polyarthritis].
Brückle W; Schattenkirchner M
Z Rheumatol; 1989; 48(1):1-5. PubMed ID: 2652936
[TBL] [Abstract][Full Text] [Related]
25. Epitope mapping of antibodies against ferritin heavy chain in giant cell arteritis and polymyalgia rheumatica.
Große K; Schmidt RE; Witte T; Baerlecken NT
Scand J Rheumatol; 2013; 42(3):215-9. PubMed ID: 23682607
[TBL] [Abstract][Full Text] [Related]
26. Serum amyloid A concentrations in giant-cell arteritis and polymyalgia rheumatica: a useful test in the management of the disease.
Hachulla E; Saile R; Parra HJ; Hatron PY; Gosset D; Fruchart JC; Devulder B
Clin Exp Rheumatol; 1991; 9(2):157-63. PubMed ID: 1711943
[TBL] [Abstract][Full Text] [Related]
27. Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations.
Salvarani C; Macchioni P; Boiardi L; Rossi F; Casadei Maldini M; Mancini R; Beltrandi E; Spacca C; Lodi L; Portioli I
J Rheumatol; 1992 Jul; 19(7):1100-6. PubMed ID: 1512765
[TBL] [Abstract][Full Text] [Related]
28. Microheterogeneity of acute phase proteins in the differentiation of polymyalgia rheumatica from polymyositis.
Pawlowski T; Aeschlimann A; Kahn MF; Vaith P; Mackiewicz SH; Mueller W
J Rheumatol; 1990 Sep; 17(9):1187-92. PubMed ID: 1705291
[TBL] [Abstract][Full Text] [Related]
29. Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: Clinical features and epidemiological data.
Pamuk ON; Dönmez S; Karahan B; Pamuk GE; Cakir N
Clin Exp Rheumatol; 2009; 27(5):830-3. PubMed ID: 19917168
[TBL] [Abstract][Full Text] [Related]
30. [Polymyalgia rheumatica--fibromyalgia-syndrome: symptoms, syndromes or diseases?].
Wermelinger F
Ther Umsch; 2006 Mar; 63(3):195-200. PubMed ID: 16613290
[TBL] [Abstract][Full Text] [Related]
31. [Comparative study of von Willebrand factor in patients with temporal arteritis].
González-Gay MA; Alvarez MD; Machín AJ; Alonso MD; García González J; Cereijo MJ; Bal M
An Med Interna; 1992 Oct; 9(10):483-6. PubMed ID: 1420759
[TBL] [Abstract][Full Text] [Related]
32. Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica.
van der Geest KS; Abdulahad WH; Rutgers A; Horst G; Bijzet J; Arends S; Roffel MP; Boots AM; Brouwer E
Rheumatology (Oxford); 2015 Aug; 54(8):1397-402. PubMed ID: 25724206
[TBL] [Abstract][Full Text] [Related]
33. A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis.
Chakravarty K; Pountain G; Merry P; Byron M; Hazleman B; Scott DG
J Rheumatol; 1995 Sep; 22(9):1694-7. PubMed ID: 8523347
[TBL] [Abstract][Full Text] [Related]
34. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH
Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883
[TBL] [Abstract][Full Text] [Related]
35. CRP in the management of polymyalgia rheumatica and giant cell arteritis.
Schreiber S
Clin Rheumatol; 1987 Mar; 6(1):97-8. PubMed ID: 3581706
[No Abstract] [Full Text] [Related]
36. Procalcitonin at the onset of giant cell arteritis and polymyalgia rheumatica: the GRACG prospective study.
Schmidt J; Duhaut P; Bourgeois AM; Salle V; Smail A; Chatelain D; Betsou F; Mazière JC; Ducroix JP;
Rheumatology (Oxford); 2009 Feb; 48(2):158-9. PubMed ID: 19098302
[TBL] [Abstract][Full Text] [Related]
37. Circulating levels of IL-1beta, IL-6 and soluble IL-2 receptor in polymyalgia rheumatica and giant cell arteritis and rheumatoid arthritis.
Pountain G; Hazleman B; Cawston TE
Br J Rheumatol; 1998 Jul; 37(7):797-8. PubMed ID: 9714363
[No Abstract] [Full Text] [Related]
38. Glucocorticoid effects on adrenal steroids and cytokine responsiveness in polymyalgia rheumatica and elderly onset rheumatoid arthritis.
Sulli A; Montecucco CM; Caporali R; Cavagna L; Montagna P; Capellino S; Fazzuoli L; Seriolo B; Alessandro C; Secchi ME; Cutolo M
Ann N Y Acad Sci; 2006 Jun; 1069():307-14. PubMed ID: 16855158
[TBL] [Abstract][Full Text] [Related]
39. Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumatica.
Baerlecken NT; Linnemann A; Gross WL; Moosig F; Vazquez-Rodriguez TR; Gonzalez-Gay MA; Martin J; Kötter I; Henes JC; Melchers I; Vaith P; Schmidt RE; Witte T
Ann Rheum Dis; 2012 Jun; 71(6):943-7. PubMed ID: 22228484
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-6 in clinical relapses of polymyalgia rheumatica and giant cell arteritis.
Caplanne D; Le Parc JM; Alexandre JA
Ann Rheum Dis; 1996 Jun; 55(6):403-4. PubMed ID: 8694583
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]